Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

Share Price Information for Ferrexpo (FXPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.55
Bid: 42.00
Ask: 42.65
Change: -2.95 (-6.63%)
Spread: 0.65 (1.548%)
Open: 44.45
High: 44.75
Low: 41.55
Prev. Close: 44.50
FXPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exchange Offer Results Announcement

23 Feb 2015 10:13

RNS Number : 5844F
Ferrexpo PLC
23 February 2015
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. NOT FOR GENERAL DISTRIBUTION IN THE UNITED STATES.

23 February 2015

FERREXPO FINANCE PLC ANNOUNCES RESULTS OF ITS EXCHANGE OFFER FOR ITS U.S.$500,000,000 7.875 PER CENT. GUARANTEED NOTES DUE 2016

FERREXPO FINANCE PLC (the "Issuer") today announces the results of its invitation to holders of its outstanding U.S.$500,000,000 7.875 per cent. Guaranteed Notes due 2016 (the "Existing Notes") to offer to exchange any and all of the Existing Notes for the New Notes and the Cash Consideration (the "Exchange Offer").

As at the Exchange Deadline, the Minimum Participation Condition has not been satisfied. However, pursuant to the Exchange Offer Memorandum, the Issuer has decided to waive the Minimum Participation Condition and will accept in full all Existing Notes which were validly submitted and received by the Exchange Agent at or prior to the Exchange Deadline pursuant to the Exchange Offer, being U.S.$214,331,000 in aggregate principal amount of Existing Notes.

The Issuer intends to issue U.S.$160,724,000 in aggregate principal amount of New Notes on the Settlement Date, expected to be on or about 24 February 2015, and pay an aggregate principal amount of Cash Consideration of U.S.$53,582,750 on the Settlement Date.

Following the Settlement Date, U.S.$285,669,000 in aggregate principal amount of Existing Notes will remain outstanding.

The Exchange Offer was made on the terms and subject to the conditions set out in the Exchange Offer Memorandum dated 19 January 2015 (the "Exchange Offer Memorandum") as amended by the announcements made by the Issuer on 4 February 2015 and 6 February 2015.

Capitalised terms used in this announcement but not defined have the meanings given to them in the Exchange Offer Memorandum.

For further information, please contact:

 

Dealer Managers

 

Credit Suisse Securities (Europe) Limited

 

 Morgan Stanley & Co. International plc

 

 

One Cabot Square

Canary Wharf

London E14 4QA

United Kingdom

Tel: +44 207 883 8763

Fax: +44 207 892 1310

Attention: Liability Management Desk

25 Cabot Square

Canary Wharf

London E14 4QA

United Kingdom

Tel: +44 207 677 5040

Email: liabilitymanagementeurope@morganstanley.com

Attention: Liability Management

 

Exchange Agent

 

 

Lucid Issuer Services Limited

Leroy House

436 Essex Road

London N1 3QP

United Kingdom

Tel: +44 (0) 20 7704 0880

Email: ferrexpo@lucid-is.com

Attention: Paul Kamminga

 

 

OFFER AND DISTRIBUTION RESTRICTIONS

Neither this announcement, nor the Exchange Offer Memorandum constitutes an invitation to participate in the Exchange Offer in any jurisdiction in which, or to any person to or from whom, it is unlawful to make such invitation or for there to be such participation under applicable securities laws. The distribution of this announcement and the Exchange Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement or the Exchange Offer Memorandum comes are required by the Issuer, the Dealer Managers and the Exchange Agent to inform themselves about, and to observe, any such restrictions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGZZGFGGKZM
Date   Source Headline
11th Feb 20227:00 amRNSChanges to Board Roles
31st Jan 202210:21 amRNSDirector/PDMR Shareholding
28th Jan 20227:00 amRNSNew Corporate Website
12th Jan 20227:00 amRNSProduction Report and Trading Update for 4Q 2021
30th Dec 20217:00 amRNSAppointment of Independent Non-executive Director
22nd Dec 20217:00 amRNSAnnouncement of Interim Dividend
16th Nov 202111:00 amRNSPresentation for Analyst Roundtable Meeting
16th Nov 20217:00 amRNSAnnouncement of Shareholder Returns Policy
11th Oct 20217:00 amRNSAnnouncement of Decarbonisation Targets
6th Oct 20217:00 amRNSProduction Report for 3Q 2021
21st Sep 20211:35 pmRNSDirector Declaration
17th Sep 202112:54 pmRNSResults of General Meeting
8th Sep 20217:00 amRNSPresentation to Institutional Investor Conference
31st Aug 20212:01 pmRNSDirector/PDMR Shareholding
25th Aug 20214:40 pmRNSHolding(s) in Company
25th Aug 20217:00 amRNSNotice of General Meeting
4th Aug 20217:01 amRNSPublication of Responsible Business Report
4th Aug 20217:00 amRNSInterim Results for six months ended 30 June 2021
19th Jul 20217:00 amRNSNotice of Interim Results
7th Jul 20217:01 amRNSAppointment of Group Chief Financial Officer
7th Jul 20217:00 amRNSProduction Report for 2Q 2021
5th Jul 20213:57 pmRNSDirector/PDMR Shareholding
1st Jul 20213:50 pmRNSHolding(s) in Company
30th Jun 20217:00 amRNSEarly Repayment of Debt Facility
28th Jun 20212:47 pmRNSHolding(s) in Company
25th Jun 20217:00 amRNSReport on Payments to Governments for 2020
23rd Jun 20215:17 pmRNSHolding(s) in Company
11th Jun 20213:32 pmRNSHolding(s) in Company
7th Jun 20214:54 pmRNSDirector Declaration
27th May 20213:00 pmRNSResults of Annual General Meeting
27th May 20217:00 amRNSAGM Presentation and Chair Address
6th May 202110:41 amRNSDirector/PDMR Shareholding
19th Apr 20213:20 pmRNSDirector/PDMR Shareholding
16th Apr 20217:00 amRNSNotice of AGM, Annual Report and Final Dividend
8th Apr 20217:00 amRNSProduction Report for 1Q 2021
17th Mar 20217:00 amRNS2020 Full Year Financial Results
1st Mar 20217:00 amRNSAppointment of Independent Non-executive Director
23rd Feb 20217:00 amRNSNotice of Full Year Results
29th Jan 20213:51 pmRNSDirector/PDMR Shareholding
13th Jan 20212:12 pmRNSDirector/PDMR Shareholding
12th Jan 20217:01 amRNSAppointment of Financial Adviser and Broker
12th Jan 20217:00 amRNSTrading Update and Production Report for 4Q 2020
5th Jan 20217:00 amRNSSpecial Interim Dividend Announcement
3rd Dec 20207:00 amRNSFerrexpo Investor Presentation
30th Nov 20207:00 amRNSKyiv Court Cancels Ferrexpo AG Share Restriction
9th Oct 20202:54 pmRNSDirector/PDMR Shareholding
6th Oct 20207:01 amRNSFerrexpo AG Court Appeal Ruling
6th Oct 20207:00 amRNSProduction Report for 3Q 2020
11th Sep 20202:20 pmRNSGeneral Meeting Voting results
11th Sep 20207:00 amRNSFerrexpo 2020 Special Interim Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.